University of Copenhagen, Panum Institute, Health faculty,
Welcome,         Profile    Billing    Logout  
 7 Trials 
13 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Lundgren, Jens
NCT06360744: A Phase IV Vaccine Study Under the National Cohort Study of Effectiveness and Safety of SARS-CoV-2 (COVID-19) Vaccines.

Completed
4
25
Europe
Johnson & Johnson
Jens D Lundgren, MD, Ministry of the Interior and Health, Denmark
SARS CoV 2 Infection
12/23
12/23
NCT05822583: Strategies and Treatments for Respiratory Infections &Amp; Viral Emergencies (STRIVE): Immune Modulation Strategy Trial

Recruiting
4
1500
Europe, US, RoW
abatacept infusion, Placebo group
University of Minnesota
COVID-19
07/25
07/25
ENFORCE, NCT04760132 / 2020-006003-42: National Cohort Study of Effectiveness and Safety of SARS-CoV-2/COVID-19 Vaccines

Completed
4
7600
Europe
COMIRNATY - BioNTech Manufacturing GmbH, COVID-19 Vaccine Moderna dispersion for injection - MODERNA BIOTECH, COVID-19 Vaccine AstraZeneca suspension for injection
Jens D Lundgren, MD, Ministry of the Interior and Health, Denmark
SARS-CoV Infection
12/23
12/23
NCT05780268: LY3819253 (LY-CoV555) for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

Completed
3
314
Europe, US, RoW
LY3819253, Placebo, Remdesivir, Veklury
National Institute of Allergy and Infectious Diseases (NIAID), International Network for Strategic Initiatives in Global HIV Trials (INSIGHT), University of Copenhagen, Medical Research Council, Kirby Institute, Washington D.C. Veterans Affairs Medical Center, AIDS Clinical Trials Group, National Heart, Lung, and Blood Institute (NHLBI), US Department of Veterans Affairs, Prevention and Early Treatment of Acute Lung Injury, Cardiothoracic Surgical Trials Network, Eli Lilly and Company, University of Minnesota
COVID-19
02/21
02/21
NCT05780424: BRII-196/BRII-198 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

Completed
3
353
Europe, US, RoW
BRII-196, BRII-198, Placebo, Remdesivir, Veklury
National Institute of Allergy and Infectious Diseases (NIAID), International Network for Strategic Initiatives in Global HIV Trials (INSIGHT), University of Copenhagen, Medical Research Council, Kirby Institute, Washington D.C. Veterans Affairs Medical Center, AIDS Clinical Trials Group, National Heart, Lung, and Blood Institute (NHLBI), US Department of Veterans Affairs, Prevention and Early Treatment of Acute Lung Injury, Cardiothoracic Surgical Trials Network, Brii Biosciences Limited, University of Minnesota
COVID-19
06/21
10/22
NCT05780281: VIR-7831 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

Completed
3
367
Europe, US, RoW
VIR-7831, Placebo, Remdesivir, Veklury
National Institute of Allergy and Infectious Diseases (NIAID), International Network for Strategic Initiatives in Global HIV Trials (INSIGHT), University of Copenhagen, Medical Research Council, Kirby Institute, Washington D.C. Veterans Affairs Medical Center, AIDS Clinical Trials Group, National Heart, Lung, and Blood Institute (NHLBI), US Department of Veterans Affairs, Prevention and Early Treatment of Acute Lung Injury, Cardiothoracic Surgical Trials Network, Vir Biotechnology, Inc., GlaxoSmithKline, University of Minnesota
COVID-19
06/21
10/22
NCT05780437: AZD7442 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

Completed
3
1455
Europe, US, RoW
AZD7442, AZD8895 + AZD1061, Placebo, Remdesivir, Veklury
National Institute of Allergy and Infectious Diseases (NIAID), International Network for Strategic Initiatives in Global HIV Trials (INSIGHT), University of Copenhagen, Medical Research Council, Kirby Institute, Washington D.C. Veterans Affairs Medical Center, Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections, National Heart, Lung, and Blood Institute (NHLBI), US Department of Veterans Affairs, Prevention and Early Treatment of Acute Lung Injury, Cardiothoracic Surgical Trials Network, AstraZeneca, University of Minnesota
COVID-19
01/22
06/23
NCT05780463: MP0420 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

Completed
3
485
Europe, US, RoW
MP0420, ensovibep, Placebo, Remdesivir, Veklury
National Institute of Allergy and Infectious Diseases (NIAID), International Network for Strategic Initiatives in Global HIV Trials (INSIGHT), University of Copenhagen, Medical Research Council, Kirby Institute, Washington D.C. Veterans Affairs Medical Center, AIDS Clinical Trials Group, National Heart, Lung, and Blood Institute (NHLBI), US Department of Veterans Affairs, Prevention and Early Treatment of Acute Lung Injury, Cardiothoracic Surgical Trials Network, Molecular Partners AG, University of Minnesota
COVID-19
02/22
06/23
TICO, NCT04501978 / 2020-003278-37: ACTIV-3: Therapeutics for Inpatients With COVID-19

Completed
3
2753
Europe, US, RoW
LY3819253, Placebo, Remdesivir, VIR-7831, BRII-196/BRII-198, AZD7442, AZD8895 + AZD1061, MP0420, ensovibep, PF-07304814
National Institute of Allergy and Infectious Diseases (NIAID), International Network for Strategic Initiatives in Global HIV Trials (INSIGHT), University of Copenhagen, Medical Research Council, Kirby Institute, Washington D.C. Veterans Affairs Medical Center, AIDS Clinical Trials Group, National Heart, Lung, and Blood Institute (NHLBI), US Department of Veterans Affairs, Prevention and Early Treatment of Acute Lung Injury, Cardiothoracic Surgical Trials Network, Eli Lilly and Company, Vir Biotechnology, Inc., GlaxoSmithKline, Brii Biosciences Limited, AstraZeneca, Molecular Partners AG, Pfizer, University of Minnesota
Covid19
04/22
07/23
NCT05780541: PF-07304814 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

Terminated
3
58
Europe, US
PF-07304814, Placebo, Remdesivir, Veklury
National Institute of Allergy and Infectious Diseases (NIAID), International Network for Strategic Initiatives in Global HIV Trials (INSIGHT), University of Copenhagen, Medical Research Council, Kirby Institute, Washington D.C. Veterans Affairs Medical Center, AIDS Clinical Trials Group, National Heart, Lung, and Blood Institute (NHLBI), US Department of Veterans Affairs, Prevention and Early Treatment of Acute Lung Injury, Cardiothoracic Surgical Trials Network, Pfizer, University of Minnesota
COVID-19
04/22
07/23
NCT05605093: Strategies and Treatments for Respiratory Infections & Viral Emergencies (STRIVE): Shionogi Protease Inhibitor (Ensitrelvir)

Recruiting
3
1500
Europe, Japan, US, RoW
Shionogi Protease Inhibitor (S-217622), ensitrelvir, placebo
University of Minnesota, National Institute of Allergy and Infectious Diseases (NIAID)
COVID-19
07/25
07/25
NCT01056185: Respiratory Virus Hospitalization Study (FLU 003 Plus)

Completed
N/A
1000
Europe, US, RoW
University of Minnesota, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Clinical & Translational Science Institute, University of Minnesota
Influenza, Novel Respiratory Virus-1 Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV), Novel Respiratory Virus-2 Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
08/24
08/24
MISTRAL, NCT05421286: The Study: Gut Microbiome Correlates of Serious AIDS and Non-AIDS Events

Active, not recruiting
N/A
1000
Europe, RoW
Rigshospitalet, Denmark, IrsiCaixa, Horizon 2020 - European Commission
HIV-1-infection, Inflammation, AIDS
12/25
12/25
Raben, Dorthe
No trials found

Download Options